MA Chun-Yan
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaXU Rui-Xia
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaYAO Yu-Hong
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaLI Xiao-Lin
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaGUO Yuan-Lin
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaZHANG Yan
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaLI Sha
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaLI Jian-Jun
Diagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, ChinaDiagnosis and Treatment Center for Dyslipidemia and Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China)
R363
MA Chun-Yan, XU Rui-Xia, YAO Yu-Hong, LI Xiao-Lin, GUO Yuan-Lin, ZHANG Yan, LI Sha, LI Jian-Jun. Inhibitory effect of berberine on proliferation of human umbilical vein endothelial cells induced by oxidized low density lipoprotein and its molecular mechanism[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(2):144-151.
Copy